Therefore, this study aimed to leverage the precision of CD4+ T cells count and the comprehensive nature of BALF-tNGS to delineate a quantitative and dynamic landscape of the pathogen profile in the BALF of patients with severe pneumonia. This evidence concerns the gene CD4 and susceptibility to pneumonia measurement.